Results for Cannabidiol

Rss Feed: Click here

A review of cannabinoids in bipolar affective disorder.

Article Published Date : Apr 30, 2005

Study Type : Review

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929), Cannabinoids : CK(2052) : AC(845), Delta-tetrahydrocannabinol (THC) : CK(2646) : AC(929)

Diseases : Bipolar Disorder : CK(433) : AC(59)

Pharmacological Actions : Anti-Anxiety Agents : CK(2913) : AC(735), Antidepressive Agents : CK(4882) : AC(1328), Sedative effects

Additional Keywords : Anti-Anxiety Agents, Antidepressive Agents, bipolar disorder, Cannabidiol, Cannabinoids, Delta-tetrahydrocannabinol (THC), Sedative effects

Click here to view the entire abstract

Cannabidiol and abnormal cannabidiol reduced the infarct volume.

Article Published Date : Apr 30, 2005

Study Type : Animal Study

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Diseases : Middle Cerebral Artery Occlusion (MCAO) : CK(109) : AC(53)

Pharmacological Actions : Neuroprotective Agents : CK(10404) : AC(6995)

Additional Keywords : Cannabidiol, Middle Cerebral Artery Occlusion (MCAO), Neuroprotective Agents

Click here to view the entire abstract

Cannabidiol exhibits an antipsychotic-like profile without inducing extrapyramidal-like effects.

Article Published Date : Apr 10, 2005

Study Type : Animal Study

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Pharmacological Actions : Antipsychotic Agents : CK(30) : AC(13)

Additional Keywords : Antipsychotic Agents, Cannabidiol, Natural Substances Versus Drugs : CK(2375) : AC(549)

Click here to view the entire abstract

Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage.

Article Published Date : Apr 06, 2017

Study Type : Animal Study

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Diseases : Brain Damage: Hypoxic Ischemic Insult : CK(13) : AC(7)

Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(13987), Neuroprotective Agents : CK(10404) : AC(6995)

Additional Keywords : Anti-Inflammatory Agents, Brain Damage: Hypoxic Ischemic Insult, Cannabidiol, Neuroprotective Agents

Click here to view the entire abstract

Cannabidiol-transdermal delivery has an anti-inflammatory effect in a murine model.

Article Published Date : Dec 11, 2003

Study Type : Animal Study

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Diseases : Inflammation : CK(9572) : AC(4849)

Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(13987)

Additional Keywords : Anti-Inflammatory Agents, Cannabidiol, Inflammation : CK(128) : AC(57)

Click here to view the entire abstract

This unjustly demonized plant is about to change the scope of medicine and disease management as we know it

Historical Maligning of Marijuana

This article is copyrighted by GreenMedInfo LLC, 2020
Visit our Re-post guidelines

If Cannabis Can Kill "Incurable" Brain Cancer, Why Is It Criminalized?

Cannabis contains a compound that may kill brain cancers that chemotherapy and radiation can't touch, so why isn't it being used today?

This article is copyrighted by GreenMedInfo LLC, 2013
Visit our Re-post guidelines

Natural Allopathic Medicine Protocol Components

Pre-clinical evidence largely shows that CBD can produce beneficial effects in AD, PD and MS patients

Article Published Date : Apr 12, 2017

Study Type : Review

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Diseases : Alzheimer's Disease : CK(3372) : AC(2000), Multiple Sclerosis : CK(1802) : AC(509), Parkinson's Disease : CK(1838) : AC(1014)

Pharmacological Actions : Neuroprotective Agents : CK(10404) : AC(6995)

Additional Keywords : Alzheimer's disease, Cannabidiol, Multiple Sclerosis : CK(38) : AC(8), Neuroprotective Agents, Parkinson's disease

Click here to view the entire abstract

This article is copyrighted by GreenMedInfo LLC, 2015
Visit our Re-post guidelines

Primary Health Benefits of Hemp

Originally published on Mercola.com.

Hemp has many health benefits to offer, and may be making its comeback in the United States.

This article is copyrighted by GreenMedInfo LLC, 2020
Visit our Re-post guidelines

Article Originally Published on www.drsircus.com

This quick overview of the science backs up the assertion that every cancer patient and every oncologist should put medical marijuana on their treatment maps

The data support a promising therapeutic profile for CBD as a new fast-acting antidepressant treatment.

Article Published Date : Jun 03, 2018

Study Type : Animal Study

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Diseases : Depression

Pharmacological Actions : Antidepressive Agents : CK(4882) : AC(1328), Brain-derived neurotrophic factor modulator : CK(672) : AC(250)

Additional Keywords : Antidepressive Agents, Brain-derived neurotrophic factor modulator, Cannabidiol, Depression : CK(108) : AC(19)

Click here to view the entire abstract

These results suggest that CBD has anxiolytic properties.

Article Published Date : Jan 31, 2004

Study Type : Human Study

Additional Links

Substances : Cannabidiol : CK(2644) : AC(929)

Diseases : Anxiety Disorders : CK(1544) : AC(238)

Pharmacological Actions : Anti-Anxiety Agents : CK(2913) : AC(735)

Additional Keywords : Anti-Anxiety Agents, Anxiety Disorders, Cannabidiol

Click here to view the entire abstract

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.